Chinese city offers cash for clues in Covid 'people's war' – ETHealthworld.com

0
241

We have updated our terms and conditions and privacy policy
Click “Continue” to accept and continue with ET HealthWorld
Dear user,

ET HealthWorld privacy and cookie policy has been updated to align with the new data regulations in European Union. Please review and accept these changes below to continue using the website.

You can see our privacy policy & our cookie policy. We use cookies to ensure the best experience for you on our website.

If you choose to ignore this message, we’ll assume that you are happy to receive all cookies on ET HealthWorld.
WHO looking forward to oral, nasal Covid vaccines
WHO warns of massive syringe shortfall in 2022

Rebooting Cancer Awareness
The unsung hero in faster holistic recovery
Technological Disruption in Indian Health & Pharma
Do you think you are up for the challenge?
Holistic Solutions For A Healthier India





17 July


Adopting-Dynamic-Technologies








As more countries lift Covid measures, Beijing officials have stuck stubbornly to a zero-Covid strategy that has maintained low infection numbers due to strict border closures, targeted lockdowns and long quarantines.
Recommended by ColombiaColumbia
125000+ Industry Leaders read it everyday
Britain on Thursday approved the use of Merck’s antiviral pill to treat patients suffering from mild to moderate Covid-19, the Medicines and Healthcare products Regulatory Agency (MHRA) announced.
The chances of a third Covid-19 wave appear remote under the “present circumstances” with only the Delta and its derivatives as the main SARS-CoV-2 variants in circulation and the weekly caseload dropping steadily, according to experts.“We need to forget about the third wave for the moment.
We have various options to advertise with us including Events, Advertorials, Banners, Mailers, Webinars etc.
Please contact us to know more details.
Get ETHealthworld‘s top stories every morning in your email inbox.
125000+ Industry Leaders read it everyday
Follow @ETHealthworld for the latest news, insider access to events and more.

source